Hélène Roussel INSERM U970 Université Paris Descartes Biography Publications Institution JoVE Articles Hélène Roussel has not added a biography. If you are Hélène Roussel and would like to personalize this page please email our Author Liaison for assistance. Publications Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung Cancer Cancers. Aug, 2017 | Pubmed ID: 28771186 Mechanisms of Action and Rationale for the Use of Checkpoint Inhibitors in Cancer ESMO Open. 2017 | Pubmed ID: 28761757 Induction of Resident Memory T Cells Enhances the Efficacy of Cancer Vaccine Nature Communications. May, 2017 | Pubmed ID: 28537262 Composite Biomarkers Defined by Multiparametric Immunofluorescence Analysis Identify ALK-positive Adenocarcinoma As a Potential Target for Immunotherapy Oncoimmunology. 2017 | Pubmed ID: 28507793 [The "immune Checkpoints", How Does It Work] Annales De Pathologie. Feb, 2017 | Pubmed ID: 28160999 [Immunotherapy in Uropathology] Annales De Pathologie. Feb, 2017 | Pubmed ID: 28111042 Tim-3 Expression on Tumor-Infiltrating PD-1+CD8+ T Cells Correlates with Poor Clinical Outcome in Renal Cell Carcinoma Cancer Research. Mar, 2017 | Pubmed ID: 27872087 Resident Memory T Cells As Surrogate Markers of the Efficacy of Cancer Vaccines Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Feb, 2016 | Pubmed ID: 26542056 Mucosal Vaccines: Novel Strategies and Applications for the Control of Pathogens and Tumors at Mucosal Sites Human Vaccines & Immunotherapeutics. 2014 | Pubmed ID: 25424921 An Allogeneic NK Cell Line Engineered to Express Chimeric Antigen Receptors: A Novel Strategy of Cellular Immunotherapy Against Cancer Oncoimmunology. Nov, 2013 | Pubmed ID: 24753987 Expression of EPHRIN-A1, SCINDERIN and MHC Class I Molecules in Head and Neck Cancers and Relationship with the Prognostic Value of Intratumoral CD8+ T Cells BMC Cancer. Dec, 2013 | Pubmed ID: 24330498 [p16 Protein in Other Than Gynecologic Lesions] Annales De Pathologie. Nov, 2010 | Pubmed ID: 21055564 Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells Clémence Granier1, Emeline Vinatier2,3,4, Elia Colin2,3, Marion Mandavit2,3, Charles Dariane2,3,5, Virginie Verkarre6, Lucie Biard7, Rami El Zein2, Corinne Lesaffre2, Isabelle Galy-Fauroux2, Hélène Roussel2,3,6, Eléonore De Guillebon8, Charlotte Blanc2,3, Antonin Saldmann4, Cécile Badoual2,6, Alain Gey*4, Éric Tartour*2,4 1PARCC-INSERM U970, Université Paris Descartes, 2INSERM U970, Université Paris Descartes, 3Equipe Labellisée Ligue Contre le Cancer, 4Department of Immunology, Hopital Européen Georges Pompidou, 5Department of Medical Urology, Hopital Européen Georges Pompidou, 6Department of Pathology, Hopital Européen Georges Pompidou, 7Université Paris Diderot Paris 7, 8Department of medical oncology, Hopital Européen Georges Pompidou JoVE 56606 Ricerca sul cancro
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells Clémence Granier1, Emeline Vinatier2,3,4, Elia Colin2,3, Marion Mandavit2,3, Charles Dariane2,3,5, Virginie Verkarre6, Lucie Biard7, Rami El Zein2, Corinne Lesaffre2, Isabelle Galy-Fauroux2, Hélène Roussel2,3,6, Eléonore De Guillebon8, Charlotte Blanc2,3, Antonin Saldmann4, Cécile Badoual2,6, Alain Gey*4, Éric Tartour*2,4 1PARCC-INSERM U970, Université Paris Descartes, 2INSERM U970, Université Paris Descartes, 3Equipe Labellisée Ligue Contre le Cancer, 4Department of Immunology, Hopital Européen Georges Pompidou, 5Department of Medical Urology, Hopital Européen Georges Pompidou, 6Department of Pathology, Hopital Européen Georges Pompidou, 7Université Paris Diderot Paris 7, 8Department of medical oncology, Hopital Européen Georges Pompidou JoVE 56606 Ricerca sul cancro